1Strom C, Sander B, Larsen N, et al. Diabetic macular edema assessed with optical coherence tomography and stereo fundus photography. Invest Ophthalmol Vis Sci, 2002,43: 241-245.
2Yamamoto S, Yamamoto T, Hayashi M, et al. Morphological and functional analyses of diabetic macular edema by optical coherence tomography and multifocal electroretinograms. Graefes Arch Clin Exp Ophthalmo1,2001,239 : 96-101.
3Otani T,Kishi S. Tomographic findings of foveal hard exudates in diabetic macular edema. Am J Ophthalmol,2001,131:50-54.
4Stefansson E. The therapeutic effects of retinal laser treatment and vitrectomy. A theory based on oxygen and vascular physiology. Acta Ophthalmol Scand ,2001,79 : 435-440.
5Gardner TW,Eller AW,Friberg TR. Reduction of severe macular edema in eyes with poor vision after panretinal photoeoagulation for proliferative diabetic retinopathy. Graefes Arch Clin Exp Ophthalmol, 1991,229 : 323-323.
6Ladas ID,Theodossiadis GP. Long-term effectiveness of modified grid laser photocoagulation for diffuse diabetic macular edema.Acta Ophthalmol (Copenh), 1993,71 : 393-397.
7Massin-Korobelnik P ,Gaudric A ,Coscas G. Spontaneous evolution and photocoagulation of diabetic cystoid macular edema. Graefes Arch Clin Exp Ophthalmol, 1994,232 : 279-289.
9Arend O,Remky A, Harris A,et al. Macular microcirculation in cystoid maculopathy of. diabetic patients. Br J Ophthalmol, 1995,79;628-632.
10Sims LM,Stoessel K, Thompson JT,et al. Assessment of visualfield changes before and after focal photocoagulation for clinically significant diabetic macular edema. Ophthalmologica, 1990,200:133-141.
6Ip MS,Gottlieb JI,Kahsna A,et a1.Intravitreal injection of eorticosteroid for the treatment of nmeular edema asscociated with central retinal vein occlusion.Arch Ophthalmol,2004,122:1131-1136.
7Michael R,Susan SL,Hyuncheol K,et a1.A rabbit model for assessing the ocular barriers to the transscleral delivery of trianacinolone aeetonide.Exp Eye Res,2006,82:479-487.
8Russo V,Barone A, Conte E,Prascina F,Stella A,Noci ND. Bevacizumab compared with macular laser grid photocoagulation for cystoid macular edema in branch retinal vein occlusion[ J]. Retina,2009,29(4) :511-515.
9Pece A,Isola V, Piermarocchi S, Calori G. Efficacy and safety of anti-vascular endothelial growth factor (VEGF) therapy with intravitreal ranibizumab (Lucentis) for naive retinal vein occlusion: 1-year follow-up [ J ], Br J Ophthalmol, 2011,95 ( 1 ) :55-58.
10Rouvas A,Petrou P, Ntouraki A, Douvali M, Ladas I, Vergados I. Intravitreal ranibizumab (Lucentis) for branch retinal vein occlusion-induced macular edema:nine-month results of a prospective study[ J]. Retina,2010,30(6) :893-902.
